Page last updated: 2024-11-03

propranolol and Staphylococcal Infections

propranolol has been researched along with Staphylococcal Infections in 7 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Elsebaei, MM1
Mohammad, H1
Abouf, M1
Abutaleb, NS2
Hegazy, YA1
Ghiaty, A1
Chen, L1
Zhang, J1
Malwal, SR1
Oldfield, E1
Seleem, MN2
Mayhoub, AS2
Shahin, IG1
Alhashimi, M1
Kassab, AE1
Mohamed, KO1
Taher, AT1
Brosnahan, AJ1
Vulchanova, L1
Witta, SR1
Dai, Y1
Jones, BJ1
Brown, DR1
Fraser, K1
Kobayashi, M1
Jeschke, MG1
Asai, A1
Kogiso, M1
Yoshida, S1
Herndon, DN1
Suzuki, F1
Alekhin, EK1
Kalimullina, DKh1
Feinroth, MV1
Goldstein, EJ1
Josephson, A1
Friedman, EA1

Other Studies

7 other studies available for propranolol and Staphylococcal Infections

ArticleYear
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
    European journal of medicinal chemistry, 2018, Mar-25, Volume: 148

    Topics: Alkynes; Animals; Anti-Bacterial Agents; Half-Life; Methicillin-Resistant Staphylococcus aureus; Mic

2018
Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
    European journal of medicinal chemistry, 2020, Sep-15, Volume: 202

    Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans;

2020
Norepinephrine potentiates proinflammatory responses of human vaginal epithelial cells.
    Journal of neuroimmunology, 2013, Jun-15, Volume: 259, Issue:1-2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Cell Line, Tra

2013
67th annual meeting of the American Academy of Dermatology: San Francisco, California, USA, 6-10 March 2009.
    American journal of clinical dermatology, 2009, Volume: 10, Issue:3

    Topics: Acne Vulgaris; Dermatology; Hemangioma; Humans; Keratosis, Actinic; Melanoma; Methicillin-Resistant

2009
Propranolol as a modulator of M2b monocytes in severely burned patients.
    Journal of leukocyte biology, 2011, Volume: 89, Issue:5

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antigens, Bacterial; Burns; Catecholamines; Child; C

2011
[Pharmacological analysis of the mechanism of action of prodigiozan].
    Antibiotiki, 1983, Volume: 28, Issue:6

    Topics: Adrenal Cortex; Animals; Cyclic AMP; Drug Interactions; Glucocorticoids; Immunity, Innate; Lethal Do

1983
Infection complicating intrapericardial steroid instillation in uremic pericarditis.
    Clinical nephrology, 1981, Volume: 15, Issue:6

    Topics: Adult; Drainage; Humans; Male; Minoxidil; Pericarditis; Propranolol; Staphylococcal Infections; Urem

1981